Carlo Monsanto
Carlo Monsanto has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Lokesh Agrawal
Universidad Integral del Caribe y América Latina, Kaminda Cas Grandi #79, Willemstad, Curacao
1 shared publication - Min-Hua Chen
Department of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City 320314, Taiwan
1 shared publication - Rajkumar Singh Kalra
Immune Signal Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan
1 shared publication - Ranjith Kumar Bakku
Faculty of Engineering Information and Systems, University of Tsukuba, 1-1-1 Tenodai, Tsukuba 305-8572, Japan
1 shared publication - Scott Eisenhower
Human Biology, School of Integrative and Global Majors, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-0006, Japan
1 shared publication - Thanasis Poullikkas
Human Biology, School of Integrative and Global Majors, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-0006, Japan
1 shared publication
Latest Publications
- Open Access
- 13 March 2024
- Published by Qeios Ltd in Qeios Preprints
Embodying Flow: Living Through The Mind-Body Continuum
Quantum social learning (QSL) is an emerging action learning approach that has been inspired by various disciplines, and specially the work of David Bohm in “rheomode” or “flow mode.” QSL uses a novel psychosocial interpretation of quantum theory to describe the central role that awareness and the heart play in synchronizing the body's systems and their activity at all scales and contexts, including how we interact socially. QSL describes awareness as a ground state, like a black hole, with a quantum potential to unfold and fold back (enfold) conscious experience. The heart acts as the seed and center of our human galaxy, attracting, shaping, and evolving the surrounding cells into tissues, organs, and other systems. We also describe how disappointments, adverse childhood experiences, and trauma keep experiences from completing and folding back and repress and suppress the same toward the unconscious background. Combining grounding and decoding processes HEAL enables us to hold space for the unresolved past experiences to be received, transformed and fold back into awareness. At the same time, cathartic transformations expand us beyond our limiting beliefs, habit patterns, and perceptions, rendering clarity and heightened awareness and presence.
- 13 March 2024
- Published by Qeios Ltd in Qeios Preprints
Open AccessEmbodying Flow: Living Through The Mind-Body Continuum
Quantum social learning (QSL) is an emerging action learning approach that has been inspired by various disciplines, and specially the work of David Bohm in “rheomode” or “flow mode.” QSL uses a novel psychosocial interpretation of quantum theory to describe the central role that awareness and the heart play in synchronizing the body's systems and their activity at all scales and contexts, including how we interact socially. QSL describes awareness as a ground state, like a black hole, with a quantum potential to unfold and fold back (enfold) conscious experience. The heart acts as the seed and center of our human galaxy, attracting, shaping, and evolving the surrounding cells into tissues, organs, and other systems. We also describe how disappointments, adverse childhood experiences, and trauma keep experiences from completing and folding back and repress and suppress the same toward the unconscious background. Combining grounding and decoding processes HEAL enables us to hold space for the unresolved past experiences to be received, transformed and fold back into awareness. At the same time, cathartic transformations expand us beyond our limiting beliefs, habit patterns, and perceptions, rendering clarity and heightened awareness and presence.
- Open Access
- 11 January 2021
- Published by MDPI AG in Antibodies
- Vol. 10 (1) , 3
Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel coronavirus for which no known effective antiviral drugs are available. In the present study, to accelerate the discovery of potential drug candidates, bioinformatics-based in silico drug discovery approaches are utilized. We performed multiple sequence alignments of the Spike (S) protein with 75 sequences of different viruses from the Orthocoronavirinae subfamily. This provided us with insights into the evolutionarily conserved domains that can be targeted using drugs or specific antibodies. Further, we analyzed the mechanism of SARS-CoV-2 core proteins, i.e., S and RdRp (RNA-dependent RNA polymerase), to elucidate how the virus infection can utilize hemoglobin to decrease the blood oxygen level. Moreover, after a comprehensive literature survey, more than 60 antiviral drugs were chosen. The candidate drugs were then ranked based on their potential to interact with the Spike and RdRp proteins of SARS-CoV-2. The present multidimensional study further advances our understanding of the novel viral molecular targets and potential of computational approaches for therapeutic assessments. The present study can be a steppingstone in the selection of potential drug candidates to be used either as a treatment or as a reference point when designing a new drug/antibody/inhibitory peptide/vaccine against SARS-CoV-2.
- 11 January 2021
- Published by MDPI AG in Antibodies
- Vol. 10 (1) , 3
Open AccessViroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel coronavirus for which no known effective antiviral drugs are available. In the present study, to accelerate the discovery of potential drug candidates, bioinformatics-based in silico drug discovery approaches are utilized. We performed multiple sequence alignments of the Spike (S) protein with 75 sequences of different viruses from the Orthocoronavirinae subfamily. This provided us with insights into the evolutionarily conserved domains that can be targeted using drugs or specific antibodies. Further, we analyzed the mechanism of SARS-CoV-2 core proteins, i.e., S and RdRp (RNA-dependent RNA polymerase), to elucidate how the virus infection can utilize hemoglobin to decrease the blood oxygen level. Moreover, after a comprehensive literature survey, more than 60 antiviral drugs were chosen. The candidate drugs were then ranked based on their potential to interact with the Spike and RdRp proteins of SARS-CoV-2. The present multidimensional study further advances our understanding of the novel viral molecular targets and potential of computational approaches for therapeutic assessments. The present study can be a steppingstone in the selection of potential drug candidates to be used either as a treatment or as a reference point when designing a new drug/antibody/inhibitory peptide/vaccine against SARS-CoV-2.